NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Company Directory Search

Endacea Inc.

Endacea Inc.

Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure.

Company Location

2 Davis Drive

Research Triangle Park
NC
27709


P.O. Box 13169

Research Triangle Park
NC
27709-2076
County
Region

Company Details

Year founded
1995
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
Small molecule for inhalational treatment of COVID 19 acute lung injury.
Gene immunotherapy for cancer.
Small molecule for treatment of sepsis and acute renal failure.